ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 55 filers reported holding ADMA BIOLOGICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,593,305 | +0.4% | 9,104,275 | +3.5% | 10.83% | -7.5% |
| Q2 2023 | $32,447,354 | +27.9% | 8,793,321 | +14.8% | 11.70% | +37.6% |
| Q1 2023 | $25,360,194 | -5.8% | 7,661,690 | +10.4% | 8.50% | -24.9% |
| Q4 2022 | $26,927,200 | +121.6% | 6,940,000 | +38.8% | 11.33% | +107.4% |
| Q3 2022 | $12,150,000 | -12.3% | 5,000,000 | -28.6% | 5.46% | -15.3% |
| Q2 2022 | $13,860,000 | +6.2% | 7,000,000 | -1.8% | 6.45% | +19.1% |
| Q1 2022 | $13,051,000 | -6.6% | 7,131,808 | -28.0% | 5.41% | -15.6% |
| Q4 2021 | $13,975,000 | +272.6% | 9,911,577 | +1091.7% | 6.41% | +181.4% |
| Q2 2018 | $3,751,000 | +1628.6% | 831,731 | +1129.5% | 2.28% | +1653.1% |
| Q4 2017 | $217,000 | – | 67,647 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |